Re-appointment of Dr. Ramesh Kancharla
RAINBOW · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Rainbow Children's Medicare Limited held its Board Meeting on May 23, 2026, approving the audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026 with an unmodified (clean) audit opinion from S.R. Batliboi & Associates LLP. The Board recommended a final dividend of ₹3.5 per equity share (35% on ₹10 face value) for FY 2025-26, payable after shareholder approval at the 28th AGM scheduled for July 29, 2026. Record date is July 21, 2026. Key appointments include the re-appointment of Dr. Ramesh Kancharla as Chairman and Managing Director for 5 years (Aug 2026-Aug 2031), Dr. Dinesh Kumar Chirla as Whole Time Director, and re-appointment of two Independent Directors (Mr. Santanu Mukherjee and Ms. Sundari R. Pisupati) for second terms. Cost auditors M/s. Lavanya & Associates LLP were also reappointed for FY 2026-27.
All director re-appointments are positive for governance continuity, with Dr. Ramesh Kancharla continuing as founding promoter Chairman and the clean audit opinion affirming financial transparency. The dividend recommendation provides shareholder returns, with payment due within 30 days of the July AGM.